Clinical Trial Update: PK, PD and Safety of Multiple Doses of V1512 Tablets in PD Patients Compared to Standard Levodopa/Carbidopa Oral Tablets [Phase 1, Phase 2]

View source ↗

Summary

Early-phase trial comparing multiple-dose PK/PD and safety of V1512 tablets against standard Levodopa/Carbidopa in Parkinson's disease patients.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Parkinson Disease

Drugs mentioned

• Levodopa/Carbidopa (levodopa/carbidopa)
• V1512

Snippet

Sponsor: Vernalis (R&D) Ltd | Conditions: Parkinson's Disease | Phase 1, Phase 2 | Status: COMPLETED